A pan-immunotherapy biomarker predicts and reactivates CD8⁺ T cell expansion, offering new insight into treatment response.

Scientists have long suspected connections between heredity and disease, dating back to Hippocrates, who observed certain ...

Genomics has administered a double dose of litigation to Illumina, joining with separate partners in a pair of federal lawsuits accusing the sequencing giant of infringing on nine patents related to ...

Carolina Molecular, a clinical sequencing lab and NGS foundry, and CS Genetics, an emerging leader in single-cell RNA ...

Bone is a common site for metastasis of solid cancers, but histological and molecular features of bone metastases are not well understood. In a new study published in Cell Genomics, researchers at ...

By examining genomic variation more closely, scientists can now identify new disease connections with greater speed and accuracy. For centuries, scientists have recognized that certain illnesses can ...

The startup, launched out of CEO Kevin Parker’s grad school idyll during the COVID lockdowns, is primed to find new targets ...

Becton, Dickinson and Company BDX, popularly known as BD, announced a multi-year collaboration with Opentrons Labworks, Inc.

Capturing spatial information is essential to elucidate how cells function and interact within their native tissue environment. However, the initial spatial transcriptomics techniques have several ...

BioSkryb Genomics and Eremid® Genomic Services announced the launch of an Early Access Program for BioSkryb’s new ResolveSEQ LongRead solution.